Format

Send to:

Choose Destination
See comment in PubMed Commons below
Blood. 2009 Mar 19;113(12):2619-28. doi: 10.1182/blood-2008-11-163501. Epub 2009 Jan 12.

Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome.

Author information

  • 1Division of Hematology/Oncology, Northwestern University, Chicago, IL 60611, USA.

Abstract

Children with Down syndrome (DS) show a spectrum of clinical anomalies, including cognitive impairment, cardiac malformations, and craniofacial dysmorphy. Moreover, hematologists have also noted that these children commonly show macrocytosis, abnormal platelet counts, and an increased incidence of transient myeloproliferative disease (TMD), acute megakaryocytic leukemia (AMKL), and acute lymphoid leukemia (ALL). In this review, we summarize the clinical manifestations and characteristics of these leukemias, provide an update on therapeutic strategies and patient outcomes, and discuss the most recent advances in DS-leukemia research. With the increased knowledge of the way in which trisomy 21 affects hematopoiesis and the specific genetic mutations that are found in DS-associated leukemias, we are well on our way toward designing improved strategies for treating both myeloid and lymphoid malignancies in this high-risk population.

PMID:
19139078
[PubMed - indexed for MEDLINE]
PMCID:
PMC2661853
Free PMC Article

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk